101 related articles for article (PubMed ID: 12534004)
1. [Young patient with stress dyspnea of uncertain origin. Evaluate for pulmonary hypertension!].
MMW Fortschr Med; 2002 Oct; 144(42):64. PubMed ID: 12534004
[No Abstract] [Full Text] [Related]
2. [Dyspnea. When is it pulmonary hypertension?].
MMW Fortschr Med; 2003 Aug; 145(33-34):62. PubMed ID: 14526588
[No Abstract] [Full Text] [Related]
3. [Endothelin receptor antagonist bosentan. Breakthrough in the treatment of pulmonary hypertension].
MMW Fortschr Med; 2004 Dec; 146(50):72-3. PubMed ID: 15666438
[No Abstract] [Full Text] [Related]
4. [PAH and many other indications. Old and new endothelin receptor antagonists.].
Schmitz J; Holzgrabe U
Pharm Unserer Zeit; 2010 Nov; 39(6):430-5. PubMed ID: 20967930
[No Abstract] [Full Text] [Related]
5. Successful treatment of persistent pulmonary hypertension of the newborn with bosentan.
Nakwan N; Choksuchat D; Saksawad R; Thammachote P; Nakwan N
Acta Paediatr; 2009 Oct; 98(10):1683-5. PubMed ID: 19523174
[TBL] [Abstract][Full Text] [Related]
6. [Bosentan for treatment of heart failure].
Yoshimoto T; Hirata Y
Nihon Rinsho; 2007 May; 65 Suppl 5():159-63. PubMed ID: 17571378
[No Abstract] [Full Text] [Related]
7. Dual endothelin receptor antagonism in pulmonary arterial hypertension.
Pittrow D; Kirch W
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():v-vi. PubMed ID: 16919003
[No Abstract] [Full Text] [Related]
8. Clinical features and endothelin receptor antagonist in primary Sjögren's syndrome with pulmonary arterial hypertension.
Chen CH; Chen HA; Yang KY; Yu WC; Liao HT; Huang DF
Scand J Rheumatol; 2006; 35(3):245-7. PubMed ID: 16766376
[No Abstract] [Full Text] [Related]
9. [Bosentan].
Taéron C
Rev Infirm; 2005 Feb; (108):33-4. PubMed ID: 15816717
[No Abstract] [Full Text] [Related]
10. Bosentan for the treatment of adult pulmonary hypertension.
Dwyer N; Kilpatrick D
Future Cardiol; 2011 Jan; 7(1):19-37. PubMed ID: 21174507
[TBL] [Abstract][Full Text] [Related]
11. A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism.
Hachulla E; Coghlan JG
Ann Rheum Dis; 2004 Sep; 63(9):1009-14. PubMed ID: 15308510
[TBL] [Abstract][Full Text] [Related]
12. Endothelin and endothelin receptor antagonists in systemic rheumatic disease.
Mayes MD
Arthritis Rheum; 2003 May; 48(5):1190-9. PubMed ID: 12746891
[No Abstract] [Full Text] [Related]
13. Thrombotic microangiopathic nephropathy, pulmonary hypertension and nephromegaly: case report of a patient treated with endothelin receptor antagonist.
Losito A; Pittavini L; Covarelli C
Clin Nephrol; 2012 Feb; 77(2):164-70. PubMed ID: 22257549
[TBL] [Abstract][Full Text] [Related]
14. Bosentan therapy for pulmonary arterial hypertension.
Rubin LJ; Badesch DB; Barst RJ; Galie N; Black CM; Keogh A; Pulido T; Frost A; Roux S; Leconte I; Landzberg M; Simonneau G
N Engl J Med; 2002 Mar; 346(12):896-903. PubMed ID: 11907289
[TBL] [Abstract][Full Text] [Related]
15. [Therapy according to current guidelines. Practical management of pulmonary arterial hypertension.].
Pabst S; Hammerstingl C; Nickenig G; Skowasch D
Pharm Unserer Zeit; 2010 Nov; 39(6):448-52. PubMed ID: 20967933
[No Abstract] [Full Text] [Related]
16. [Endothelin].
Maeda S; Miyauchi T; Goto K
Nihon Rinsho; 2006 Jul; 64 Suppl 5():112-6. PubMed ID: 16895176
[No Abstract] [Full Text] [Related]
17. [Pulmonary arterial hypertension--a rare form of pulmonary hypertension].
Schenk M
Dtsch Med Wochenschr; 2010 May; 135(21):p21. PubMed ID: 20509110
[No Abstract] [Full Text] [Related]
18. Diagnosis of pulmonary arterial hypertension in a patient with systemic sclerosis.
Distler JH; Hoeper MM; Distler O
Nat Clin Pract Rheumatol; 2008 Mar; 4(3):160-4. PubMed ID: 18212761
[TBL] [Abstract][Full Text] [Related]
19. Bosentan for chronic thromboembolic pulmonary hypertension.
Confalonieri M; Kodric M; Longo C; Vassallo FG
Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1503-12. PubMed ID: 19954311
[TBL] [Abstract][Full Text] [Related]
20. [Course of pulmonary artery hypertension disease].
Hoeper MM
Krankenpfl J; 2005; 43(4-6):113. PubMed ID: 16171059
[No Abstract] [Full Text] [Related]
[Next] [New Search]